Predictive and Prognostic Implications of EGFR Mutations
作者： Federico Cappuzzo
DOI: 10.1007/978-3-319-03059-3_4
关键词:
摘要: Several studies have suggested that epidermal growth factor receptor (EGFR) mutations are themselves associated with improved prognosis independent of treatment.
springer.com
sci-hub.st 参考文章(25)
W.K. (Bill) Evans, Gefitinib does not improve survival when combined with paclitaxel and carboplatin chemotherapy in people with advanced non-small-cell lung cancer Cancer Treatment Reviews. ,vol. 30, pp. 655- 659 ,(2004) , 10.1016/J.CTRV.2004.08.002
Federico Cappuzzo, Claudio Ligorio, Luca Toschi, Elisa Rossi, Rocco Trisolini, Daniela Paioli, Elisabetta Magrini, Giovanna Finocchiaro, Stefania Bartolini, Alessandra Cancellieri, Fred R. Hirsch, Lucio Crino, Marileila Varella-Garcia, EGFR and HER2 gene copy number and response to first-line chemotherapy in patients with advanced non-small cell lung cancer (NSCLC). Journal of Thoracic Oncology. ,vol. 2, pp. 423- 429 ,(2007) , 10.1097/01.JTO.0000268676.79872.9B
William Pao, Vincent A Miller, Katerina A Politi, Gregory J Riely, Romel Somwar, Maureen F Zakowski, Mark G Kris, Harold Varmus, Acquired Resistance of Lung Adenocarcinomas to Gefitinib or Erlotinib Is Associated with a Second Mutation in the EGFR Kinase Domain PLoS Medicine. ,vol. 2, pp. e73- ,(2005) , 10.1371/JOURNAL.PMED.0020073
Susumu Kobayashi, Titus J. Boggon, Tajhal Dayaram, Pasi A. Jänne, Olivier Kocher, Matthew Meyerson, Bruce E. Johnson, Michael J. Eck, Daniel G. Tenen, Balázs Halmos, EGFR Mutation and Resistance of Non–Small-Cell Lung Cancer to Gefitinib The New England Journal of Medicine. ,vol. 352, pp. 786- 792 ,(2005) , 10.1056/NEJMOA044238
Ming-Sound Tsao, Akira Sakurada, Keyue Ding, Sarit Aviel-Ronen, Olga Ludkovski, Ni Liu, Aurélie Le Maître, David Gandara, David H. Johnson, James R. Rigas, Lesley Seymour, Frances A. Shepherd, Prognostic and Predictive Value of Epidermal Growth Factor Receptor Tyrosine Kinase Domain Mutation Status and Gene Copy Number for Adjuvant Chemotherapy in Non-small Cell Lung Cancer Journal of Thoracic Oncology. ,vol. 6, pp. 139- 147 ,(2011) , 10.1097/JTO.0B013E3181FD83A4
Takayuki Kosaka, Yasushi Yatabe, Ryoichi Onozato, Hiroyuki Kuwano, Tetsuya Mitsudomi, Prognostic Implication of EGFR, KRAS, and TP53 Gene Mutations in a Large Cohort of Japanese Patients with Surgically Treated Lung Adenocarcinoma Journal of Thoracic Oncology. ,vol. 4, pp. 22- 29 ,(2009) , 10.1097/JTO.0B013E3181914111
Chia-Chi Lin, Hsin-Hsin Hsu, Chia-Tung Sun, Jin-Yuan Shih, Zhong-Zhe Lin, Chong-Jen Yu, George G. Chen, Michael Kuan Yew Hsin, Kwok Chi Lam, Linda Leung, Chih-Hsin Yang, Tony Mok, Chemotherapy Response in East Asian Non-small Cell Lung Cancer Patients Harboring Wild-Type or Activating Mutation of Epidermal Growth Factor Receptors Journal of Thoracic Oncology. ,vol. 5, pp. 1424- 1429 ,(2010) , 10.1097/JTO.0B013E3181E9DB73
Lecia V. Sequist, Renato G. Martins, David Spigel, Steven M. Grunberg, Alexander Spira, Pasi A. Jänne, Victoria A. Joshi, David McCollum, Tracey L. Evans, Alona Muzikansky, Georgiana L. Kuhlmann, Moon Han, Jonathan S. Goldberg, Jeffrey Settleman, A. John Iafrate, Jeffrey A. Engelman, Daniel A. Haber, Bruce E. Johnson, Thomas J. Lynch, First-Line Gefitinib in Patients With Advanced Non–Small-Cell Lung Cancer Harboring SomaticEGFRMutations Journal of Clinical Oncology. ,vol. 26, pp. 2442- 2449 ,(2008) , 10.1200/JCO.2007.14.8494
Jean-Yves Douillard, Frances A. Shepherd, Vera Hirsh, Tony Mok, Mark A. Socinski, Radj Gervais, Mei-Lin Liao, Helge Bischoff, Martin Reck, Mark V. Sellers, Claire L. Watkins, Georgina Speake, Alison A. Armour, Edward S. Kim, Molecular Predictors of Outcome With Gefitinib and Docetaxel in Previously Treated Non–Small-Cell Lung Cancer: Data From the Randomized Phase III INTEREST Trial Journal of Clinical Oncology. ,vol. 28, pp. 744- 752 ,(2010) , 10.1200/JCO.2009.24.3030
Giuseppe Giaccone, Roy S. Herbst, Christian Manegold, Giorgio Scagliotti, Rafael Rosell, Vincent Miller, Ronald B. Natale, Joan H. Schiller, Joachim von Pawel, Anna Pluzanska, Ulrich Gatzemeier, John Grous, Judith S. Ochs, Steven D. Averbuch, Michael K. Wolf, Pamela Rennie, Abderrahim Fandi, David H. Johnson, Gefitinib in Combination With Gemcitabine and Cisplatin in Advanced Non–Small-Cell Lung Cancer: A Phase III Trial—INTACT 1 Journal of Clinical Oncology. ,vol. 22, pp. 777- 784 ,(2004) , 10.1200/JCO.2004.08.001